C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Sales | 21,381 | 0 | 0 | 0 |
| Gross Profit | 21,381 | N/A | N/A | N/A |
| Operating Expenses | 56,833 | 0 | 0 | 0 |
| Operating Income | -35,452 | N/A | N/A | N/A |
| Interest Expense | -2,157 | 0 | 0 | 0 |
| Pre-tax Income | -33,295 | 0 | 0 | 0 |
| Income Tax | 804 | N/A | N/A | N/A |
| Net Income Continuous | -34,099 | N/A | N/A | N/A |
| Net Income | $-34,099 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -31.03 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -24.85 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -31.03 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -24.85 | N/A | N/A | N/A |
| EBITDA(a) | $-33,523 | $N/A | $N/A | $N/A |